EWG Elevate’s Cardinal Health CAH Stock Holding History

EWG Elevate’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-639	Closed	-$49.1K	–	166
2022 Q4	$49.1K	Buy	+639	New	+$48.6K	0.02%	182

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EWG Elevate's CAH Position: Q1 2023 in Review

EWG Elevate sold out of Cardinal Health (CAH) in Q1 2023, closing a stake of 639 shares — an estimated $49.1K sold.

EWG Elevate first reported a position in CAH in Q4 2022 and held it in 1 quarter. The position peaked at $49.1K in Q4 2022. 907 funds tracked by Wall St. Rank hold CAH as of Q1 2023.

EWG Elevate reported no remaining Cardinal Health position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 639 Cardinal Health shares in Q1 2023, an estimated $49.1K.
EWG Elevate first reported a position in Cardinal Health in Q4 2022 and held it in 1 quarter.
EWG Elevate's Cardinal Health position peaked at $49.1K in Q4 2022.
907 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.